The video focus on the pathophysiology of Cardiovascular-Kidney-Metabolic (CKM) syndrome, the clinical staging of patients with chronic kidney disease (CKD), key screening parameters like eGFR and urine albumin-creatinine ratio (UACR), and kidney-protective pharmacotherapies (such as SGLT2 inhibitors and finerenone)